title: Efficacy but side effects of anakinra therapy for chronic refractory gout in a renal transplant recipient with preterminal chronic renal failure.
authors: Guillaume
authors: G
authors: Direz
authors: Natacha
authors: N
authors: Noël
authors: Charlotte
authors: C
authors: Guyot
authors: Olivier
authors: O
authors: Toupance
authors: Jean-Hugues
authors: JH
authors: Salmon
authors: Jean-Paul
authors: JP
authors: Eschard
mesh_terms: D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D002908:Chronic Disease; D005260:Female; D006073:Gout / Q000188:drug therapy*; D006084:Graft Rejection / Q000150:complications; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000150:complications*; D016030:Kidney Transplantation; D009503:Neutropenia / Q000139:chemically induced / Q000175:diagnosis; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein; D017472:Receptors, Interleukin-1